(2) Benefits to Other Interested Parties As discussed in the CY 2020 HPT final rule (84 FR 65538) and the CY 2026 OPPS/ASC proposed rule (90 FR 33856), we believe public access to hospital standard charge information can be useful to the public, including patients who need to obtain services from a hospital, consumers of healthcare who wish to view hospital standard charge information prior to selecting a hospital, employers and State governments searching for lower cost options for health care coverage, and other users of the MRF who may develop consumer-friendly price transparency tools or perform price analyses to uncover disparities or drive value-based policy development
Not only has it been demonstrated to be a potent pro-angiogenic factor, but it has also been shown to be an anti-inflammatory, cytoprotective, and endothelial-protective agent that could counteract several well-established side effects of prolonged NSAID (Non-steroidal anti-inflammatory drugs) use [2]
It's frustrating, and it's avoidable
Disclaimer: This article is intended for licensed medical professionals
Individual patient characteristics also play crucial roles
( ( We received public comments on this proposal